Clinical exome sequencing
Our largest NGS panel available is CentoDx Plus™, covering over 3,200 diseases in the shortest turnaround time. It targets only genes associated with known clinical phenotypes, thereby comprising the complete clinical exome and reducing additional costs.
Who will benefit from CentoDx Plus™?
- Patients with unknown phenotype where whole exome sequencing is not affordable
- Patients with identified phenotype in need of a large NGS panel
- Physicians needing knowledge about clinically relevant genes
The CentoDx Plus™ advantage
Why you should choose CentoDx Plus™?
|CENTOGENE products||Genes||Coverage||Information content||Likelihood of detecting a specific mutation|
|Clinical exome sequencing - CentoDx Plus™||~6,700||~95% >20x||~15MB||~94.1%|
|Whole exome sequencing - CentoXome®||~20,000||~97% >10x||~60MB||~93.2%|
|NGS Panel Genomic||~10-1,000||~99% >10x||200-500MB||~99.1%|
- Bone, skin & immunological
- Ear, nose & throat